04 Mar
Congress’ Remedy for Post-marketing part 2
When Caroline Loew, PhD, Senior Vice President of Scientific and Regulatory Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), appeared before a House committee in May 2007, she gave a more expansive analysis of MedWatch’s flaws: